MEGAN DONALD: Open Payments
NPI 1275965634 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 46 payments from 12 companies in 2025. Trend: 2023 $884 · 2024 $1,327 · 2025 $831
Food & beverage: $815Education: $16
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $229 |
| PFIZER INC. | 6 | $127 |
| AstraZeneca Pharmaceuticals LP | 6 | $101 |
| Lilly USA, LLC | 5 | $98 |
| Sumitomo Pharma America, Inc. | 3 | $53 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Amgen Inc. | 3 | $46 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Gilead Sciences, Inc. | 1 | $19 |
Products named: ELIQUIS, Wegovy, Ozempic, MOUNJARO, GEMTESA, AIRSUPRA, SPRAVATO, OTEZLA.
Industry payments across GA — which companies pay providers there.
